NEW YORK, Sept. 06, 2017 -- Gainey McKenna & Egleston announces that it has voluntarily dismissed its action filed against Mallinckrodt Public Limited Company (“Mallinckrodt”) in the United States District Court for the Eastern District of Missouri and refiled its action in the United States District Court for the District of Columbia, Case No. 17-cv-01827. The action is still brought on behalf of the Company’s Employee Stock Purchase Plan (“ESPP”), against certain Defendants, to cover those persons who purchased or otherwise acquired Mallinckrodt stock between November 25, 2014 and January 18, 2017 (“Relevant Period”) in the ESPP. The action brings claims under § 11 of the Securities Act of 1933 as well as claims under state law for breach of fiduciary duty, non-disclosure and breach of contract.
If you wish to serve as lead plaintiff, you must move the United States District Court for the District of Columbia no later than September 22, 2017. If you wish to join the litigation, or to discuss your rights or interests regarding this class action, please contact Thomas J. McKenna, Esq. or Gregory M. Egleston, Esq. of Gainey McKenna & Egleston at (212) 983-1300, or via e-mail at [email protected] or [email protected].


FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
Italy Fines Apple €98.6 Million Over App Store Dominance
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland 



